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DHA has been established. We propose that DHA-
containing lysophosphatidylcholine (DHA-LPC), obtained 
from DHA-rich eggs may be a suitable form of DHA and 
choline (the precursor of acetylcholine) supplementation. 
We evaluated the effectiveness of DHA-LPC to increase 
DHA and acetylcholine concentration in the brain of pups 
born from female rats supplemented with DHA-LPC before 
and during pregnancy. We also evaluated the effect of DHA 
supplementation on learning and memory capabilities of pups 
through the Skinner test for operant conditioning. Female 
Wistar rats received 40-day supplementation of DHA-LPC (8 
mg DHA/kg b.w/daily.), before and during pregnancy. After 
delivery, plasma, erythrocyte, liver, and adipose tissue DHA 
and plasma choline were analyzed. Brains from 60 day-old 
pups separated into frontal cortex, cerebellum, striatum, 
hippocampus, and occipital cortex, were assessed for DHA, 
acetylcholine, and acetylcholine transferase (CAT) activity. 
Pups were subjected to the Skinner box test. DHA-LPC 
supplementation produces higher choline and liver DHA 
contents in the mother’s plasma and increases the pups’ 
DHA and acetylcholine in the cerebellum and hippocampus. 
CAT was not modified by supplementation. The Skinner test 
shows that pups born from DHA-LPC supplemented mothers 
exhibit better scores of learning and memory than the 
controls. Conclusion: DHA-LPC may be an adequate form for 
DHA supplementation during the perinatal period.
KEY-WORDS: Brain acetylcholine – Choline – DHA 
supplementation – Lysophospholipids – Skinner box test. 
1. INTRODUCTION
The brain and retina of mammals contain very 
high amounts of long-chain polyunsaturated fatty 
acids (LC-PUFA), particularly arachidonic acid 
(20:4, omega-6, AA), and docosahexaenoic acid 
(22:6, omega-3, DHA) (Carlson & Neuringer, 
1999; Crawford, 2000). These fatty acids are 
formed from two dietary precursors; linoleic acid 
(18:3, omega-6, LA) for AA, and alpha-linolenic 
acid (18:3, omega-3, LNA) for DHA (Marszalek 
& Lodish, 2005). LA is largely available from 
the normal western diet, and therefore AA is 
not restrictive for brain and retina development 
(Simopoulos, 1999). However, the normal supply of 
RESUMEN
La suplementación de ratas hembras con DHA-
lisofosfatidilcolina aumenta el contenido de ácido doco-
sahexaenoico y de acetilcolina cerebral y mejora la capa-
cidad de aprendizaje y de memorización de las crías
El ácido docosahexaenoico (DHA) que requiere el feto y el 
recién nacido lo aporta la madre desde sus reservas y la dieta, 
por lo cual se sugiere suplementar a la madre con DHA. No 
hay consenso sobre la mejor forma de suplementación. Pro-
ponemos que un lisofosfolípido que contiene DHA y colina 
(DHA-LPC) obtenido de huevos con alto contenido de DHA es 
adecuado para suplementar DHA y colina, precursora de la 
acetilcolina. Se evaluó la efectividad de DHA-LPC para incre-
mentar el DHA y la acetilcolina cerebral de crías de ratas su-
plementadas con DHA-LPC antes y durante la gestación, y en 
la capacidad de aprendizaje y memorización de las crías me-
diante el test de condicionamiento operante de Skinner. Ratas 
Wistar hembras fueron suplementadas con DHA-LPC (8 mg 
DHA/kg/día) 40 días antes y durante la preñez. Después del 
parto se analizó DHA en plasma, eritrocitos, hígado y tejido 
adiposo, y colina plasmática. A las crías de 60 días se les se-
paró: corteza frontal, cerebelo, striatum, hipocampo y corteza 
occipital y se les analizó DHA, acetilcolina y la actividad de 
acetilcolina transferasa (CAT). Las crías fueron sometidas al 
test de Skinner. La suplementación con DHA-LPC aumenta la 
colina plasmática y el DHA hepático en las madres y el DHA y 
la acetilcolina del cerebelo e hipocampo en las crías. La activi-
dad CAT no se modifica. Las crías de madres suplementadas 
con DHA-LPC mostraron puntajes de memorización y apren-
dizaje superior que las controles. Conclusión: el aporte de 
DHA y colina como DHA-LPC puede constituir una nueva for-
ma para proveer suplementación prenatal con DHA.
PALABRAS-CLAVES: Acetilcolina cerebral – Colina – 
Lisofosfolípidos – Suplementación con DHA – Test de Skin-
ner.
SUMMARY
Supplementing female rats with DHA-
lysophosphatidylcholine increases docosahexaenoic 
acid and acetylcholine contents in the brain and 
improves the memory and learning capabilities of the 
pups
Docosahexaenoic acid (DHA) is supplied to the foetus 
and newborn through the mother from their own reserves and 
their diet. No consensus about the best form to supplement 
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al., 1992; Lemaitre-Delaunay et al., 1999; Lagarde et 
al., 2001). DHA-LPC simultaneously provides DHA 
and choline, the precursor of the neurotransmitter 
acetylcholine which is involved in memory and 
learning. Therefore, using the rat as an experimental 
model, in this report we analyzed the effect of DHA 
supplementation of mothers with DHA-LPC, obtained 
from commercial DHA-enriched eggs and compared 
to DHA-MG, in the DHA accretion and acetylcholine 
content in different brain segments of the pups, 
and in the memory and learning capabilities of the 
pups evaluated through the Skinner test of operant 
conditioning.
2. MATERIALS AND METHODS
2.1. Materials 
Components of the synthetic diet were locally 
purchased. Solvents and reagents were obtained 
from Merck Química Chilena (Santiago, Chile). 
Fatty acid standards for gas-chromatography 
and reagents for fatty acid methyl ester derivative 
preparation were obtained from Sigma Chemical, 
St. Louis, MO, USA. sn-2 Monooleyltriacylglycerol 
(O-MG) was purchased from Nu-Check Prep 
(Elysian, MN, USA). DHA-MG (96% pure, 60.9% 
DHA, 80.4% at the sn-2 position was prepared 
according the procedure of Nieto et al., (1999). 
Immobilized Fungamyl 2799 (10,000 units/mg), 
prepared by Novo Nordisk, Denmark was a gift 
from Novo Brasil (Sao Paulo, Brasil). Coconut 
oil triacylglyceride fraction (0.2% all-rac-alpha 
tocopherol) was a gift from Laboratorio Andrómaco 
(Santiago, Chile). Skinner boxes (30  10  25 cm) 
(two) and pellets for the operant conditioning test 
were purchased from Letica, Barcelona, España. 
2.2.  Animals, diet, and supplementing 
protocols
Recently weaned female Wistar rats (22-25 day-
old, n  45) weighing 75-85 g were fed a synthetic 
diet as described by Watkins et al (2000). The 
diet contained 8% vegetable fat composed of a 
mixture of olive oil, sunflower oil, and soybean oil 
(saturated, monounsaturated, and polyunsaturated 
fatty acids 1:1:1 w/w, omega-6/omega-3 ratio 
10:1). The formula provided 0.26g/100g of LNA 
to their diet, and virtually 0g DHA. Animals were 
separated into three experimental groups (n  15 
each), and received the diet for a 40-day period. 
Supplementation was initiated at day 40 of 
feeding the synthetic diet. DHA-MG and DHA-LPC 
groups were daily supplemented to an amount 
which provided 8 mg/kg b.w. of DHA (which is 
close to the suggested supplementation of DHA 
for women, Simopulos et al., 1999). The control 
group was supplemented daily with O-MG to an 
amount equivalent to 8 mg/kg b.w of oleic acid. 
Oils were given by gastric instillation dissolved in a 
triacylglyceride fraction of coconut oil into a volume 
LNA is frequently very low, and preformed DHA is 
even much lower (Crawford, 2000). DHA is present 
in large proportion in the grey matter of the brain’s 
cerebral cortex, which constitutes 15-20% of the 
total fatty acids in the brain. It is believed that DHA 
plays an important role in regulating the fluidity of 
neuronal membranes, and thus the efficiency of 
neuroelectrical signal transmissions (Marszalek & 
Lodish, 2005; Valenzuela, 2009). In humans, the 
highest amount of DHA is produced during the last 
trimester of pregnancy and also during the first two 
years of life (Clandinin, 1999; Wainwright, 2002). 
In the rat, the highest amount of DHA is produced 
from day 12 of gestation until the weaning of the 
pups (Martin & Bazan, 1992). DHA is supplied to 
the foetus by the mother through the placenta 
during pregnancy and through the breast milk 
during nursing (Crawford, 2000). Mammalian milk 
contains a small but nutritionally significant amount 
of DHA (0.2-0.4%), which is strongly dependent 
on the mother’s availability of the fatty acid (or of 
its precursor, LNA) (Jensen, 1999). At present, 
formulas which replace breast milk contain added 
DHA in order to avoid a shortage of the fatty 
acid during pregnancy and nursing, mainly after 
frequent pregnancies and/or multiparous deliveries 
(Innis, 2004; Innis, 2007). DHA supplementation to 
the mother is now recommended during perinatal 
period (pregnancy and nursing), and even before 
the beginning of pregnancy (Salem et al, 2001). A 
mother’s perinatal DHA supplementation has been 
associated with improved scores of memory and 
learning capabilities in humans (Willatts et al, 1998; 
Koo, 2003; Bakker et al., 2003; Judge et al., 2007; 
NEMO Study group, 2007), and in experimental 
animals such as rats (Moriguchi et al., 2000), and 
mice (Carrié et al., 2000), when evaluated through 
the Morris water maze test (Lim & Suzuki, 2000; 
Suzuki et al., 2001), or the resolution radial 12 arms 
maze test (Carrié et al., 2002). Helland et al (2003) 
demonstrated that maternal omega-3 LC-PUFA 
supplementation during pregnancy and lactation 
increases children’s IQ at 4 years of age. 
Efforts have been made to provide perinatal 
DHA supplementation. DHA can be provided from 
various natural sources and in different degrees 
of purity: single-cell algae triacylglycerides (TG), 
egg yolk phospholipids (PL), pure DHA as an ethyl 
ester derivative (EE) and sn-2 docosahexaenyl 
monoacylglyceride (DHA-MG), are the main sources 
of DHA for perinatal supplementation (Garg et al., 
2006; Valenzuela et al., 2006). We have comparatively 
evaluated the effect of these DHA sources in female 
Wistar rats when the fatty acid is supplied during the 
perinatal period, observing that DHA-MG appears to 
be the best supplementing source (Valenzuela et al., 
2005). However, it has been demonstrated in rats that 
the blood transports DHA from the liver, which is the 
main physiological reservoir and source of the fatty 
acid, to the extra hepatic tissues is in the form of sn-
2 DHA lysophosphatidylcholine (DHA-LPC), which is 
highly permeable to the placenta and therefore, highly 
available for DHA accretion by the foetus (Thiés et 
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evaluation of learning capabilities (Sloan et al., 
2006). The latency to the operant conditioning is a 
measurement of the retained capabilities (memory) 
to previously learned operations (Massaro & 
Widmayer, 1981; Tikhonrarov, 2000). The care of 
animals during each experimental period was in 
compliance with the Guidelines of the Research 
Scientific Council of the University of Chile for 
Animal Care and Use.
2. 4. Analytical procedures
DHA-LPC was prepared from DHA-rich 
phosphatidylcholine obtained from omega-3 
commercial eggs (250 mg DHA/egg, Agrícola 
Nutraomega, Santiago, Chile) by a modification of 
the enzymatic procedure described by Sonada et 
al (2002) using Fungamyl 2599. Plasma choline 
concentration was measured according the 
enzymatic procedure of Ozarda et al., (2003) which 
uses choline kinase and 32P-ATP. Acetylcholine 
from brain segments was measured by the HPLC 
procedure described by Auld et al., (2001). CAT 
activity was evaluated according the method 
of Smith et al., (2004) using 3H-acetyl-CoA as 
substrate. Total lipids from the brain segments 
were extracted according to Folch et al., (1957). A 
measurement of total phospholipids from the lipid 
extracts was estimated from the measurement 
of total phosphorus (Pi) as described by Duck-
Chong (1979). Methyl ester derivatives of the lipids 
extracted from plasma, erythrocytes, liver, adipose 
tissue and each brain segment were prepared 
according to the method of Morrison and Smith 
(1964). Gas chromatography was performed in 
an Agilent 6890 N gas chromatograph equipped 
with a slit injector, using an SP-2560 capillary 
column (30m x 0.25 mm inner diameter, Supelco, 
Bellefonte, PA, USA) The column temperature was 
increased from 140°C to 240°C at 2°C per min and 
the detector temperature was 260°C. Hydrogen 
gas was used as carrier and tricosanoic acid (23:0) 
as internal standard.
2.5. Expression of results and statistics
Plasma choline concentration was expressed 
as nmoles/L. Brain acetylcholine concentration was 
expressed as nmoles/g wet tissue. CAT activity was 
expressed as nmoles 3H-acetate/mg of protein/hour. 
AA and DHA concentrations were expressed as: ug/
mL for plasma; ug/mg tissue for adipose tissue; mg/
total phospholipids for liver and erythrocytes; and 
mg/100 mg total phospholipids for brain segments. 
The results represent the average  SD. Statistical 
significance of differences between mean values 
was assessed by analysis of variance coupled 
to Duncan’s multiple range test (Duncan, 1957). 
Significance was set at p  0.05. * Notation was 
used for significant differences of DHA-supplements 
and the control and ** notation for significant 
difference between supplements.
which provided 8 mg/kg of DHA or oleic acid in 1.0 
mL. Animal weight was controlled every morning at 
9:00 before instillation to calculate the amount of oil 
to be supplied. At day 40 of DHA-supplementation 
rats from each group were mated (three females 
were caged with one male) and once fecundation 
took place (by the observation of sperm from 
vaginal samples under microscope) female 
rats were reincorporated into their respective 
experimental group, restarting the supplementation 
until delivery. Immediately after delivery, 5 mothers 
from each experimental group were sacrificed 
by decapitation under light anaesthesia to obtain 
blood, liver, and retroperitoneal adipose tissue. 
Blood was separated by centrifugation for the 
evaluation of plasma choline concentration. 
Lipids were extracted from plasma, erythrocytes, 
liver, and adipose tissue samples, for fatty acid 
composition. The remaining mothers were allowed 
to freely nurse their pups. After weaning, male 
pups selected by similar weight were separated 
from mothers in separate cages according to their 
experimental group (10 animals/cage) and fed the 
synthetic diet. At day-60 ten animals from each 
experimental group were sacrificed by decapitation 
under light anaesthesia to remove the brain 
for further analysis. Frontal cortex, cerebellum, 
striatum, hippocampus, and occipital cortex were 
rapidly excised for determination of acetylcholine 
concentration and choline acetyltransferase activity 
(CAT) and processed for total lipid extraction for 
fatty acid composition analysis. The remaining 
animals were subjected to the Skinner box test for 
operant conditioning (Staddon & Cerutti, 2003). 
2.3. Skinner box test
Three walls of each box were non transparent 
(black) and the front wall transparent. Animals, 
previously fasted over night, were subjected to a 
week of training (20 minutes/day) to familiarize 
themselves with the association “pressing the 
lever and obtaining pellet”. The light inside the box 
remained off during training. This was defined as 
the pre-conditioning test period. After this period, 
animals were trained for another week to associate 
“pressing the lever and obtaining pellet” which only 
occurs when the light inside the Skinner box was 
on. This was the operant conditioning test period 
(Staddon & Cerutti, 2003). After these assays were 
performed, animals were returned to their cages for 
a 5-day period. After this wash-out period animals 
fasted over-night were subjected again to the 
operant conditioning test (association pressing the 
lever and obtaining pellet when light is on). This 
was the latency to the operant conditioning. For 
each assay a score was established for positive 
responses (ie, pressing the lever and obtaining 
pellet and pressing the lever and obtaining pellet 
when the light is on) expressed as percentage 
of successful tasks against the total tries in a ten 
minute assay period. The pre-conditioning test 
and the operant conditioning test allow for the 
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supplementation allows for a higher content of DHA 
than DHA-MG supplementation. This is important 
because liver has a pivotal importance in the 
distribution of LC-PUFA to extra hepatic tissues during 
pregnancy, specifically to the placenta (Dutta-Roy, 
2000). A higher hepatic DHA content may produce 
a better efficiency in the delivery of the fatty acid to 
peripheral tissues. This may represent a physiological 
advantage for DHA-LPC supplementation compared 
to DHA-MG supplementation. As DHA concentration 
increases in the liver, AA concentration is reduced. 
This effect may result from the competition of these 
two fatty acids for the same substituting position in 
hepatic phospholipids. AA may be substituted, either 
at the sn-1 or sn-2 position of phospholipids. However 
DHA preferentially occupies the sn-2 position, 
therefore displacing AA from this position (Marszalek 
& Lodish, 2005).
Figure 3 shows AA and DHA contents in 
phospholipids extracted from the frontal cortex 
(A), cerebellum (B), striatum (C), hippocampus 
(D) and occipital cortex (E) obtained from the 
pups delivered by mothers supplemented with 
DHA-MG or DHA-LPC. As can be observed, both 
supplements increase the DHA content in the brain 
segments analyzed. However, differences are 
observed for the cerebellum and hippocampus. At 
these brain segments, DHA-LPC supplementation 
allows a higher accretion of DHA than DHA-MG 
supplementation. AA concentration is not modified, 
showing similar levels to the control in the brain 
segments analyzed.
Figure 4 shows acetylcholine concentration 
of the different brain segments obtained from the 
pups. It is interesting that DHA-LPC increases the 
concentration of the neurotransmitter at the frontal 
cortex, cerebellum and hippocampus, not modifying 
the acetylcholine concentration in the striatum and 
occipital cortex. When compared to the control, 
DHA-MG supplementation does not produce any 
modification of acetylcholine concentration in the 
brain segments studied.
Figure 5 shows CAT activity in the brain 
segments removed from the pups. This important 
3. RESULTS
Figure 1 shows plasma choline concentration 
obtained from mothers at delivery after DHA-MG and 
DHA-LPC supplementation. As can be observed, 
DHA-MG does not produce any modification of 
plasma choline. However, DHA-LPC supplementation 
produces a significant increase in plasma choline 
concentration. 
Figure 2 shows AA and DHA contents in plasma 
triacylglycerides (A), adipose tissue (B), liver (C) 
and erythrocytes (D) of samples obtained from 
DHA-supplemented mothers at delivery. Plasma 
triacylglycerides, adipose tissue and erythrocytes 
show similar levels of DHA when both supplementing 
sources are compared, being significantly higher 
than the control. These results demonstrate that 
DHA, when provided either as DHA-MG or DHA-
LPC is similarly incorporated into these tissues. AA 
levels are not modified by supplementation. Liver 
shows a different behavior because DHA-LPC 
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delivery.
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enzyme, which is involved in the biosynthesis of 
acetylcholine, shows different levels of enzymatic 
activity in the different brain segments. Higher 
values for cerebellum and hippocampus are 
observed, with a small and almost similar activity 
in the frontal cortex, striatum and occipital cortex. 
DHA supplementation does not modify the activity 
of the enzyme. This differential effect can be 
interpreted as follows; the higher concentration 
of acetylcholine observed at the frontal cortex, 
cerebellum, and hippocampus after DHA-LPC 
supplementation results from the higher availability 
of choline provided by DHA-LPC as substrate for 
the enzyme and not from a higher activity of the 
enzyme in these brain segments.
Figure 6 shows results obtained from the 
Skinner box test after the pre-conditioning training 
test, the operant conditioning training test and 
the latency to the application of the operant 
conditioning test. DHA-LPC supplementation 
produced a higher score of positive responses at 
the three modalities of the test. DHA-MG produces 
only a better response than the control at the pre-
conditioning training test.
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4. DISCUSSION 
After the suggestion of Expert Committees 
to include omega-3 LC-PUFA in infant formulas 
(Simopoulos et al., 1999), efforts were made to 
identify suitable sources for DHA supplementation. 
Refined and deodorized fish oil was initially used 
because of its availability and relative high content 
of DHA. However, fish oil contains EPA which 
has been implicated in adverse effects in the 
growth of premature infants (Carlson & Neuringer, 
1999). Therefore new sources were developed. At 
present, DHA is available from as single cell algae 
oil, free DHA or the ethyl ester derivative, from egg 
phospholipids, or as monoacylglyceride. Algae 
oil is expensive, ethyl esters have low availability, 
phospholipids are not generally accepted (these 
are frequently used in Europe but not in the 
Americas) and monoacylglycerides are experimental 
products at present not available as commercial 
products (Valenzuela et al., 2006). We focussed on 
phospholipids for two reasons. First, in mammalian 
tissues DHA is mainly acylated to phospholipids 
and not to triacyglycerides (Holub, 1978). Second, 
technologically, phospholipids easily form water-oil 
emulsions which allow their incorporation to different 
water-containing food matrixes. This is very important 
when DHA, as a nutritional supplement, must be 
added to fluid milk, yogurt, juices, etc (Valenzuela 
et al., 2006). Intestinal absorption of phospholipids 
needs previous hydrolysis by a phospholipase to 
be converted into lysophospholipids, which are 
further resterified at the intestinal cells and finally 
transported into quilomicrons to peripheral tissues, 
finally returning to the liver as remnant chylomicrons 
(Kritchevsky, 1995). The liver constantly releases 
lysophospholipids, mainly lysophosphatidylcholine, 
which are bound to plasma albumin and delivered 
to different tissues (Thies et al., 1992). During 
pregnancy, the liver releases DHA-LPC and in less 
proportion DHA-lysophosphatidylserine which are 
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using the Morris water maze test (Lim & Suzuki, 
2000; Suzuki et al., 2001), or the radial arm-maze 
test (Carrié et al., 2002). Both tests are primarily 
used to evaluate the working memory and do not 
allow the evaluation of capabilities under more 
complex conditioning situations (Jonasson, 2005), 
such as pellet supply when the light is on in the 
Skinner box. Therefore, in our opinion, the Skinner 
test provides a more suitable procedure to evaluate 
learning and memory capabilities. Results from the 
Skinner test for operant conditioning demonstrated 
that pups from DHA-LPC supplemented mothers 
show improved learning (pre-conditioning and 
operant conditioning tests) and memory (latency 
to pre-conditioning test) than pups nursed by 
mothers supplemented with DHA-MG and the 
control oil. A number of reports establish that DHA 
supplementation increases neurite outgrowth that 
needs higher levels of DHA in the growth cone, 
which is important during neurodevelopment 
and for the acquisition of learning and memory 
capabilities (Martin & Bazan, 1992; Innis & De la 
Presa, 2001). According to our information, this 
is the first time that the Skinner test is applied to 
an omega-3 fatty acid supplementing protocol. 
Through the use of DHA-LPC as a nutritional 
supplement, we combined the beneficial effect of 
choline and DHA supplementation, increasing the 
learning and memory capabilities of pups from 
mothers that received the supplement during the 
perinatal period. Maternal supplementation with 
DHA during pregnancy and lactation may increase 
children’s intelligence, as was demonstrated by 
Heland et al., (2003). DHA-LPC appears to be a 
good source of DHA and choline. In summary, we 
propose that DHA-LPC may constitute an adequate 
experimental form to provide both DHA and choline 
supplementation during the perinatal period. 
However, further assays are needed to validate 
the future of DHA-LPC as the best way to provide 
DHA supplementation into infant formulas. We are 
currently working on this issue.
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